Literature DB >> 29427239

Carbon Dioxide-Generating PLG Nanoparticles for Controlled Anti-Cancer Drug Delivery.

Hyeon Jin Jang1, Eun Ju Jeong1, Kuen Yong Lee2,3.   

Abstract

PURPOSE: Poly(D,L-lactide-co-glycolide) (PLG) nanoparticles containing doxorubicin and mineralized calcium carbonate were fabricated and their anti-tumor efficacy was tested using a neuroblastoma-bearing mouse model.
METHODS: PLG nanoparticles were prepared by a double emulsion (water-in-oil-in-water; W/O/W) method. Calcium carbonate was mineralized within the PLG nanoparticles during the emulsion process. Rabies virus glycoprotein (RVG) peptide was chemically introduced to the surface of the PLG nanoparticles as a targeting moiety against neuroblastoma. The cytotoxicity and cellular uptake characteristics of these nanoparticles were investigated in vitro. Moreover, their therapeutic efficacy was evaluated using a tumor-bearing mouse model.
RESULTS: Mineralized calcium carbonate in PLG nanoparticles was ionized at acidic pH and generated carbon dioxide gas, which resultantly accelerated the release of doxorubicin from the nanoparticles. RVG peptide-modified, gas-generating PLG nanoparticles showed a significantly enhanced targeting ability to neuroblastoma and an increased therapeutic efficacy in vivo as compared with free doxorubicin.
CONCLUSIONS: Targeting ligand-modified polymer nanoparticles containing both anti-cancer drug and mineralized calcium carbonate could be useful for cancer treatment.

Entities:  

Keywords:  cancer; drug delivery; gas-generation; polymer nanoparticle

Mesh:

Substances:

Year:  2018        PMID: 29427239     DOI: 10.1007/s11095-018-2359-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.

Authors:  Hyun-Jong Cho; In-Soo Yoon; Hong Yeol Yoon; Heebeom Koo; Yu-Jin Jin; Seung-Hak Ko; Jae-Seong Shim; Kwangmeyung Kim; Ick Chan Kwon; Dae-Duk Kim
Journal:  Biomaterials       Date:  2011-11-09       Impact factor: 12.479

Review 2.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

3.  Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking.

Authors:  Praveena Mohan; Natalya Rapoport
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

Review 4.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.

Authors:  Fabienne Danhier; Olivier Feron; Véronique Préat
Journal:  J Control Release       Date:  2010-08-24       Impact factor: 9.776

Review 5.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

6.  Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly(ethylene glycol)-b-poly(L-histidine).

Authors:  Eun Seong Lee; Kyung Taek Oh; Dongin Kim; Yu Seok Youn; You Han Bae
Journal:  J Control Release       Date:  2007-08-16       Impact factor: 9.776

Review 7.  Therapeutic nanoparticles for drug delivery in cancer.

Authors:  Kwangjae Cho; Xu Wang; Shuming Nie; Zhuo Georgia Chen; Dong M Shin
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

Review 8.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

9.  Microbubbles from gas-generating perfluorohexane nanoemulsions for targeted temperature-sensitive ultrasonography and synergistic HIFU ablation of tumors.

Authors:  Yang Zhou; Zhigang Wang; Yu Chen; Hongxia Shen; Zhenchun Luo; Ao Li; Qi Wang; Haitao Ran; Pan Li; Weixiang Song; Zhu Yang; Hangrong Chen; Zhibiao Wang; Guangmin Lu; Yuanyi Zheng
Journal:  Adv Mater       Date:  2013-06-21       Impact factor: 30.849

10.  Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles.

Authors:  Malgosia M Pakulska; Irja Elliott Donaghue; Jaclyn M Obermeyer; Anup Tuladhar; Christopher K McLaughlin; Tyler N Shendruk; Molly S Shoichet
Journal:  Sci Adv       Date:  2016-05-27       Impact factor: 14.136

View more
  2 in total

Review 1.  DNA Vaccines-How Far From Clinical Use?

Authors:  Dominika Hobernik; Matthias Bros
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

Review 2.  Nucleic Acid-Based Approaches for Tumor Therapy.

Authors:  Simone Hager; Frederic Julien Fittler; Ernst Wagner; Matthias Bros
Journal:  Cells       Date:  2020-09-09       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.